MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Sangamo Biosciences Company Profile (NASDAQ:SGMO)

Consensus Ratings for Sangamo Biosciences (NASDAQ:SGMO) (?)
Ratings Breakdown: 8 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $18.50 (205.79% upside)

Analysts' Ratings History for Sangamo Biosciences (NASDAQ:SGMO)
Show:
DateFirmActionRatingPrice TargetActions
5/3/2016Wells FargoInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/3/2016WedbushReiterated RatingOutperform$30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/10/2016JPMorgan Chase & Co.Reiterated RatingOverweight$16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/17/2015Janney Montgomery ScottInitiated CoverageBuy$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/23/2015Jefferies GroupInitiated CoverageBuy$12.00 -> $14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/28/2015Piper JaffrayReiterated RatingBuy$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/4/2015Cowen and CompanyReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/19/2015BMO Capital MarketsReiterated RatingOutperform$19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/4/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha